New York A02156 amends the social services law to include medical assistance for patients undergoing oral or injectable ovulation enhancing drugs.
New York A02156 amends the social services law to expand medical assistance for patients in the process of oral or injectable ovulation enhancing drugs. This includes coverage for the treatment itself, office visits, hysterosalpingogram services, pelvic ultrasounds, and blood testing, all limited to services necessary for monitoring the treatment. If federal funding is not available, state appropriations will fund a grant program to achieve the same purpose. This change aims to improve outcomes for patients undergoing these treatments.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.